Jimmy focuses his practice on the preparation and prosecution of U.S. and foreign patents in the biotechnology and pharmaceutical fields. He provides a full range of patent law services to his clients, including developing and managing their worldwide patent portfolios, assisting in patent matters in connection with strategic alliance and technology transfer transactions and conducting freedom-to-operate, invalidity and non-infringement opinion analysis.
Jimmy, with a doctoral degree in molecular and cell biology, is experienced in patent cases involving molecular biology; developmental biology; stem cells; tissue engineering; immunology; antibodies; vaccines; CRISPR/Cas genome editing, anti-sense technology; RNAi; protein, gene and cell-based therapies; diagnosis or treatments for various disorders; MRI imaging; transgenic plant; genomics; proteomics; bioinformatics; chip-array technologies; biomaterials; drug discovery; and herbal medicine.
Jimmy has prosecuted thousands of patent applications nationally and internationally. He recently secured the following patents:
U.S. Patent No. 9,005,935 – Methods and compositions for DNA fragmentation and tagging by transposases
U.S. Patent No. 8,992,942 – Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as Diagnostic Reagents and Vaccines
U.S. Patent No. 8,969,416 – Polyvinylpyrrolidone – containing acetaminophen liquid formulations
U.S. Patent No. 8,890,261 – Treatment of Angiogenesis disorders
U.S. Patent No. 8,883,454 – DNA Polymerase fusions and uses thereof
U.S. Patent No. 8.772,006 – Compositions and methods utilizing DNA polymerases
U.S. Patent No. 8,715,660 – Treatment of Angiogenesis disorders
U.S. Patent No. 8,686,129 – Methods for the biological separation of materials using sulfolane
U.S. Patent No. 8,685,676 – Multi-site mutagenesis
U.S. Patent No. 8,460,217 – Electronic pelvic organ prolapse quantification system
U.S. Patent No. 8,563,308 – Culture-expanded T suppressor cells and methods of use thereof
Before Fox Rothschild
Before joining the firm, Jimmy was an associate at a boutique intellectual property firm. He also was a patent agent for five years at Fish Richardson PC.
Prior to his legal career, Jimmy conducted research on neural and heart development at Columbia University as a graduate student. During his time at Columbia University, Jimmy’s Ph. D. thesis was awarded With Distinction. He later held a postdoctoral fellowship at Harvard Medical School where he conducted research on oncology, immunology, stem cells and hematopoiesis. Jimmy also advised the business technology group of an international pharmaceutical company on integration issues while studying at the Johnson Graduate School of Management at Cornell University.